Lobbying

Mindbloom's latest lobbying report covers Q2 2023, at $70K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medical/Disease Research/Clinical Labs.

Mindbloom

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Mindbloom lobbying by quarter
Mindbloom lobbying by quarter
QuarterAmountReports
Q4 2022$100K1
Q1 2023$100K1
Q2 2023$70K1
Q3 2023$00
Q4 2023$00
Q1 2024$00
Q2 2024$00
Q3 2024$00
Q4 2024$00
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Health issues$75.8K · 3 reports
  • Medical research and clinical labs$75.8K · 3 reports
  • Pharmacy$75.8K · 3 reports
  • Veterans$42.5K · 2 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES3 reports
  • SENATE3 reports

Firms it paid

Firm
Alpine Group Partners$270K3 quarters

Former officials lobbying for it

Former position
GREG WALDENUS Congressman 1999-2021Q2 2023
HANNAH SCHMIDTProfessional Staff, House Small Business CmteQ2 2023
JENNIFER FORRESTExecutive Asst. Rep. Greg WaldenQ2 2023

Lobbying reports

Filed by
23/07/18for Q2 2023Alpine Group Partners$70K
23/04/20for Q1 2023Alpine Group Partners$100K
23/01/19for Q4 2022Alpine Group Partners$100K